Faced with geopolitics and trade war, U.S. companies in China report record-low new investment plans
WASHINGTON — American companies in China are reporting record-low new investment plans for this year and declining confidence in profits, while uncertainty in U.S.-China relations and President Donald Trump's tariffs have become their top concerns, according to a business survey released Wednesday.
The companies are also challenged by China's slowing economy, where weak domestic demand and overcapacity in local industries are eroding profitability for the Americans.
'Businesses in China are less profitable now than they were years ago, but risks, including reputational risk, regulatory risk, and political risk, are increasing,' said Sean Stein, the president of the U.S.-China Business Council, a Washington-based group that represents American companies doing business in China, including major multinationals.
The survey, conducted between March and May and drawing from 130 member companies, came after the two countries clashed over tariffs and non-tariff measures, including export controls on critical products such as rare-earth magnets and advanced computer chips. Following high-level talks in Geneva and London, U.S. and Chinese officials agreed to pull back from sky-high tariffs and restrictions on exports, but uncertainty persists as the two sides are yet to hammer out a more permanent trade deal.
Kyle Sullivan, vice president of business advisory services at the USCBC, said more than half of the companies in the survey indicated they do not have new investment plans in China 'at all' this year.
'That's a record high,' Sullivan said, noting that it is ''a new development that we have not observed in previous surveys.'
Around 40 per cent of companies reported negative effects from U.S. export control measures, with many experiencing lost sales, severed customer relationships, and reputational damage from being unreliable suppliers, according to the survey. Citing national security, the U.S. government has banned exports to China of high-tech products, such as the most advanced chips, which could help boost China's military capabilities.
Stein argued that export controls must be very carefully targeted, because businesses from Europe or Japan, or local businesses in China would immediately fill the void left by American companies.
Silicon Valley chipmaker Nvidia won approval from the Trump administration to resume sales to China of its advanced H20 chips used to develop artificial intelligence, its CEO Jensen Huang announced on Monday, though the company's most powerful chips remain under U.S. export control rules.
While 82 per cent of U.S. companies reported profits in 2024, fewer than half are optimistic about the future in China, reflecting concerns over tariffs, deflation, and policy uncertainty, according to the survey.
Also, a record high number of American businesses plan to relocate their business operations outside of China, Sullivan said, as 27 per cent of the members indicated so, up from 19 per cent the year before.
In a departure from past surveys, concerns over China's regulatory environment, including risks of intellectual property misuse and lack of market access, didn't make it to the top five concerns this year. That's likely a first, and not for a good reason, Stein said.
'It is not because things got dramatically better on the Chinese side, but the new challenges, often coming from the U.S., are now posing as much of a challenge,' Stein said.
Almost all the American companies said they cannot remain globally competitive without their Chinese operations.
A survey from the European Union Chamber of Commerce in China in May found that European companies were cutting costs and scaling back investment plans in China as its economy slows and fierce competition drives down prices.
---
Fu Ting, The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
3 Top Growth Stocks to Buy in the Second Half of 2025
Key Points Alibaba is a Chinese AI stock that's dirt cheap. Meta Platforms is making a huge bet on AI that should pay off handsomely. Vertex Pharmaceuticals is expanding into new indications. 10 stocks we like better than Vertex Pharmaceuticals › For decades, Jim McKay introduced ABC's Wide World of Sports with a memorable phrase, "The thrill of victory, and the agony of defeat." McKay's words could apply to many investors in the first half of this year. There have been periods of victory -- and periods of defeat. Of course, the level of victory and defeat investors experienced depended on which stocks they owned. If you want greater chances of winning going forward, the stocks you pick will make a huge difference. Which stocks should you consider? Here are three top growth stocks to buy in the second half of 2025. 1. Alibaba Group Holding Wall Street loves Alibaba Group Holding (NYSE: BABA). Of the 40 analysts surveyed by LSEG in July, 37 rated the stock as a "buy" or a "strong buy." The three outliers recommended holding Alibaba. The consensus 12-month price target reflects an upside potential of roughly 40%. I'm not always on the same page as Wall Street analysts, but I agree with the upbeat views about Alibaba. For one thing, you can't even spell Alibaba without A and I. "Lbaba" just doesn't have the same ring to it. Alibaba is an artificial intelligence (AI) juggernaut in China. Its Alibaba Cloud unit commands 36% of the Chinese cloud infrastructure market, almost twice the market share of its nearest rival. Revenue from Alibaba Cloud's AI-related products has grown by triple-digit percentages for seven consecutive quarters. The company also operates China's leading e-commerce platform. Alibaba's Taobao and Tmall online shopping sites continue to deliver solid revenue growth, and AI is helping improve the user experience on the platforms. But the main reason I like Alibaba is its valuation. The stock trades at a forward earnings multiple of only 10.3. That's dirt cheap for a tech giant that raked in $137.3 billion in revenue and $17.4 billion in profits in its last fiscal year. 2. Meta Platforms Meta Platforms (NASDAQ: META) could be an underappreciated leader in AI. It's not a pure-play AI company like OpenAI. It's not a cloud titan like Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT), and Alphabet 's (NASDAQ: GOOG)(NASDAQ: GOOGL) Google. However, Meta is making a huge bet on AI that I suspect will pay off handsomely. That wager is already paying off in some ways. For example, AI is helping Meta improve its recommendation models. The company has seen a 5% higher conversion rate on Reels in the latest quarter. Over the last six months, Meta's recommendation system improvements have led to a 7% increase in user time spent on Facebook and 6% on Instagram. More time on these social media apps translates to higher advertising revenue for Meta. AI-powered business messaging presents a tremendous growth opportunity for the company. Businesses in developing nations such as Thailand and Vietnam use Meta's messaging apps heavily to communicate with customers. With AI, this model could be deployed in the U.S. and other major markets. Perhaps the most intriguing arena for Meta, though, is in AI devices. The company is already a leader in smart glasses thanks to its Ray-Ban Meta AI glasses. Its Quest virtual reality headsets remain highly popular with users. I think Meta could be one of the biggest players in a potentially massive AI device market over the next few years. 3. Vertex Pharmaceuticals Not every great growth stock that I recommend buying in the second half of 2025 is focused heavily on AI. Vertex Pharmaceuticals (NASDAQ: VRTX) is a drugmaker with terrific growth prospects. So far in Vertex's history, cystic fibrosis (CF) has been the company's primary focus. That's worked out quite well for the big biotech innovator. Vertex markets the only therapies that treat the underlying cause of CF. Its latest CF drug, Alyftrek, offers the most convenient dosing in its lineup and will almost certainly become a blockbuster quickly. However, Vertex has expanded its horizons to other therapeutic areas. Casgevy, the first approved CRISPR gene-editing therapy, targets two rare blood disorders -- sickle cell disease and transfusion-dependent beta-thalassemia. Earlier this year, Journavx became the first new class of pain medication approved by the U.S. Food and Drug Administration in more than two decades. As a powerful pain drug that isn't an opioid, I expect this new product will become another huge winner for Vertex. And there are potentially more big winners on the way. Vertex's pipeline features three other drugs in late-stage clinical testing. Inaxaplin targets APOL1-mediated kidney disease. Povetacicept's first targeted indication is chronic kidney disease IgA nephropathy. Zimislicel holds the potential to cure severe type 1 diabetes. I like the chances of success for all three programs. Should you invest $1,000 in Vertex Pharmaceuticals right now? Before you buy stock in Vertex Pharmaceuticals, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!* Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Keith Speights has positions in Alphabet, Amazon, Meta Platforms, Microsoft, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Alphabet, Amazon, Meta Platforms, Microsoft, and Vertex Pharmaceuticals. The Motley Fool recommends Alibaba Group and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
CTV News
2 hours ago
- CTV News
How will the proposed NASA budget cuts impact Canada?
York University's Paul Delaney breaks down how $6-billion in cuts to NASA's funding may pave the way for China to dominate the space race. As NASA faces the threat of US$6 billion in cuts under U.S. President Donald Trump's budget request, one astronomy expert says Canada will certainly feel the impact if the drastic financial reductions go through. Paul Delaney, former director of the Allan I. Carswell Astronomical Observatory, told CTV Your Morning on Thursday the budget cuts will severely impact every single program in NASA, making it the largest financial assault on the space agency in history. In turn, it could position other countries, namely China, to take the lead in space exploration. China is swiftly pushing forward in space exploration, with plans to put humans on the moon by early 2030. 'There is little doubt that…(NASA) will take second place,' Delaney said. He also expects that the financial threat to the space agency will lead to more privatization in the sector. Delaney said the cuts to NASA's budget will directly impact not just the Canadian Space Agency, but all researchers that are involved in space science. One item that Delaney says may be on the chopping block is the latest version of the Canada Arm, or Canadarm3, which is the country's contribution to the U.S.-led Gateway project, a space station in lunar orbit. 'The impact on Canada, in terms of both hardware generation, as well as research, could be extremely significant, forcing us of course to go elsewhere to lend our expertise,' he said. Delaney adds that the fall out from the budget cuts will run deeper than putting 'boots on Mars'. 'Your cellphone technology has been powered in very large measure by the types of activities we've developed going into space,' he said. 'The spin-offs are almost incalculable.' CNN reported on Thursday that more than 2,000 agency employees are set to voluntarily leave NASA in the coming months under the Trump administration's 'deferred resignation' program, introduced by former Trump ally Elon Musk, who is CEO of NASA's largest contractor, SpaceX.
Globe and Mail
4 hours ago
- Globe and Mail
Billionaire Bill Ackman Sells Alphabet (Google) and Buys a Robotaxi Stock Up 266% Since 2023 (Hint: Not Tesla)
Key Points Hedge fund billionaire Bill Ackman sold shares of Alphabet and took a substantial stake in Uber during the first quarter. Alphabet is gaining market share in cloud computing due to expertise in artificial intelligence (AI), but the company is battling antitrust lawsuits Uber is the most logical partner for autonomous driving companies looking to launch robotaxi services because it dominates the global ride-sharing market. 10 stocks we like better than Alphabet › Billionaire Bill Ackman is a prominent hedge fund manager well known for holding a relatively small number of high-conviction stocks. His firm, Pershing Square Capital Management, currently has $12 billion invested in 11 companies. Ackman made a few interesting capital allocation decisions in the first quarter. He sold shares of megacap Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) and bought Uber Technologies (NYSE: UBER), a stock that has returned 266% since January 2023. The trades are detailed below: He sold 772,000 shares of Alphabet, trimming his position 7%. That is surprising because most analysts viewed the stock as undervalued throughout the first quarter, and the same is true today. The median target price of $200 per share implies 9% upside from Alphabet's current share price of $183. He bought 30.3 million shares of Uber, now his largest holding at 19% of the portfolio. Ackman explained his confidence on social media, praising the leadership of CEO Dara Khosrowshahi and calling Uber "one of the best-managed and highest-quality businesses in the world." Here's what investors should know about Alphabet and Uber. Alphabet: The stock Bill Ackman sold in the first quarter Alphabet is the largest adtech company in the world. Popular web properties like Google Search and YouTube helped the company capture more than a third of global digital ad spending last year, roughly equivalent to its market share in the previous year. However, the company is projected to lose share as competitive pressure intensifies in the future. To elaborate, Amazon has become a formidable player in the digital advertising industry due to its ability to engage shoppers, and the company is likely to take share in the future as businesses spend more on retail advertising. But generative artificial intelligence (AI) platforms like OpenAI and Perplexity also threaten to siphon ad dollars away from Alphabet. Alphabet's Google is the third-largest public cloud in terms of infrastructure and platform services (CIPS) revenue. It captured 12% of CIPS spending in the first quarter of 2025, up from 11% last year, according to Synergy Research. As a recognized leader in AI infrastructure, large language models, and data science platforms, the company may continue to gain share in future quarters. Beyond its core businesses, Alphabet's Waymo is an early leader in autonomous driving technology. It already provides commercial autonomous ride-sharing services in five U.S. cities and plans to launch in at least two more next year. Waymo is also testing its robotaxi fleet in several other U.S. cities. Management said in April the company currently delivers more than 250,000 paid rides per week. Looking ahead, eMarketer estimates digital ad spending will grow at 10% annually through 2028, and Grand View Research expects the cloud computing market to increase at 20% annually through 2030. Collectively, Alphabet has a good shot at low-double-digit annual sales growth through the end of the decade, with room for upside if its robotaxi business continues to gain momentum. Wall Street estimates Alphabet's earnings will increase at 14% annually over the next three to five years. That makes the current valuation of 20.5 times earnings look reasonable. But investors should be aware that Alphabet is currently caught into two legal battles, and the associated risks may explain why Ackman trimmed his position in the first quarter. To elaborate, courts have already determined Alphabet has an illegal monopoly in internet search and adtech software, and the cases have moved into the remedies phase. While a breakup seems unlikely, the Justice Department wants Alphabet to divest certain parts of its business. A federal judge will decide on the remedy for its internet search monopoly in August, and the remedies hearing regarding its adtech software will begin in September. Uber: The stock Bill Ackman bought in the first quarter Uber has a strong presence in the mobility and food delivery markets. Specifically, it is the largest ride-sharing platform and the second-largest food delivery platform in the U.S., as measured by sales. More broadly, Uber operates the largest ride-sharing platform in the 10 largest markets worldwide, and the largest food delivery service in eight of the top 10 markets. That makes Uber a logical partner for autonomous vehicle (AV) companies. CEO Dara Khosrowshahi sees robotaxis as at $1 trillion opportunity in the U.S. alone, and he recently told analysts, "Uber can deliver the lowest operational costs for our AV partners because we are leaps and bounds ahead on every aspect of the go-to-market capabilities." Indeed, Uber has already partnered with several companies that have either launched or plan to launch robotaxi services in the near future. The most conspicuous exception is Tesla, but several consequential partnerships are detailed below: Alphabet's Waymo offers robotaxi rides through Uber in Phoenix, Austin, and Atlanta. Also, autonomous food delivery is available through Uber Eats in Phoenix. May Mobility will offer robotaxi rides through Uber in Arlington, Texas, by the end of 2025. The companies will take their partnership to additional U.S. markets in 2026. Pony AI will offer robotaxi rides through Uber in a "key market in the Middle East" this year, with a goal of scaling to additional international markets in the future. Volkswagen will offer robotaxi rides through Uber in Los Angeles. Testing is scheduled to start later this year, and the commercial launch will follow in 2026. WeRide offers robotaxi rides through Uber in Abu Dhabi, with Dubai to follow later this year. The companies will expand the partnership to 15 additional cities in the next five years. Wall Street estimates Uber's earnings will increase at 25% annually over the next three to five years. That makes the current valuation of 15.9 times earnings look relatively cheap. I think investors should follow Ackman's lead and take a stake in Uber stock, though I would start with a small position. Should you invest $1,000 in Alphabet right now? Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!* Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Trevor Jennewine has positions in Amazon and Tesla. The Motley Fool has positions in and recommends Alphabet, Amazon, Tesla, and Uber Technologies. The Motley Fool recommends Volkswagen Ag. The Motley Fool has a disclosure policy.
